Significant Ownership of GSK plc

Signature - Title
/s/ Victoria A. Whyte - Victoria A. Whyte, Authorized Signatory
Location
London
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GSK plc.

Notify me when GSK plc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of GSK plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRO SPERO THERAPEUTICS, INC. Common Stock, Par Value $0.001 16% $6,709,142 9,190,606 GSK PLC 27 Mar 2025
CVAC CureVac N.V. Common Shares, par value (euro) 0.12 per share 0% $0 -$87,937,266 0 -100% GSK plc 03 Dec 2025

Schedules 13D/G Reported by GSK plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.